Revised Schedule-M Archives - Express Pharma

The high cost of compromise: Why patient safety must come first

FOPE & PharmaState Academy advance MSME excellence with PULSE session 24 on contract management

Session 21 of FOPE, PharmaState Academy’s PULSE Program, advances excellence in manufacture of APIs under revised schedule M

FOPE, PharmaState Academy’s 16th PULSE Session held on Oral Liquids manufacturing under Revised Schedule M

What the new drug rules mean for quality control in Pharma: From lab to license

FOPE and PharmaState Academy conduct session on sterile drug manufacturing under Revised Schedule M

FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for Revised Schedule M

Understanding opportunities and challenges for SMEs after breather on Schedule M deadline

Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M

Revised Schedule M implementation for MSMEs extended, industry welcomes move